Harmony's lead new drug candidate receives 2 FDA designations

The experimental therapy is being developed to treat cataplexy and narcolepsy.

Source: bizjournals.com Health Care:Physician Practices headlines - May 31, 2018 Category: American Health Authors: John George Source Type: news